Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT

This article has been updated

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Change history

  • 28 October 2022

    The name of Ana Jimenez Ubieto was given incorrect in HTML version of the article. Correct is: Given name: Ana Family name: Jimenez Ubieto.

References

  1. Klyuchnikov E, von Pein UM, Ayuk FA, Christopeit M, Adjalle R, van Randenborgh A, et al. Daratumumab is an effective and safe salvage therapy in relapsed/refractory patients with multiple myeloma after allogeneic stem cell transplantation. Blood. 2016;128:3437.

    Article  Google Scholar 

  2. Krishnan A, Parameswaran H, Chhabra S, Biran N, Stiller T, Htut M, et al. Incidence and timing of graft versus host disease (GVHD) after daratumumab (Dara) anti CD38 therapy post allogeneic transplant (alloHCT) for myeloma. Clin Lymphoma Myeloma Leuk. 2017;17:e71.

    Article  Google Scholar 

  3. Lonial S, Weiss BM, Usmani SZ, Singhal S, Chari A, Bahlis NJ, et al. Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial. Lancet. 2016;387:1551–60. https://doi.org/10.1016/S0140-6736(15)01120-4.

    Article  CAS  PubMed  Google Scholar 

  4. Lavi N, Okasha D, Sabo E, Oren I, Benyamini N, Bar-Yoseph H. Severe cytomegalovirus enterocolitis developing following daratumumab exposure in three patients with multiple myeloma. Eur J Haematol. 2018;101:699–702. https://doi.org/10.1111/ejh.13164.

    Article  Google Scholar 

  5. Frerichs KA, Bosman PWC, Nijhof IS, Zweegman S, van de Donk N. Cytomegalovirus reactivation in a patient with extensively pretreated multiple myeloma during daratumumab treatment. Clin Lymphoma Myeloma Leuk. 2019;19:e9–e11. https://doi.org/10.1016/j.clml.2018.10.002.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported in part by the Spanish grant of Instituto de Salud Carlos III (PI16/01485) and FEDER European Union.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana Pilar Gonzalez-Rodriguez.

Ethics declarations

Conflict of interest

APG-R has served as speaker and member of advisory boards from Janssen and Celgene and Takeda. MVM has served as speaker and member of advisory boards from Janssen, Amgen, Celgene, Takeda, GSK, Abbvie, EDO, and Pharmamar. LR has served as speaker and member of advisory boards from Janssen, Amgen, Celgene, and Takeda. MAH has served as speaker and member of advisory boards from Janssen, Amgen, Celgene, and Takeda. LLC, DFM, AJG-H, PP, AB, TZR, PSD, SG-M, JZ, AJU, FdeA, CS-B, AL-S, and SG declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gonzalez-Rodriguez, A.P., Lopez-Corral, L., Fajardo, D.F.M. et al. Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT. Bone Marrow Transplant 55, 461–463 (2020). https://doi.org/10.1038/s41409-019-0525-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-019-0525-1

This article is cited by

Search

Quick links